Assignee
SCICLONE PHARMACEUTICALS INT LTD
KY·3 granted patents·1 pending application·4 citations·filing 2016–2020
Top patents by PatentIndex Score
4 records- 0182US11524056B2Thymosin alpha 1 for use in treatment of cystic fibrosisSCICLONE PHARMACEUTICALS INT LTD·Filed 2019·Granted Dec 13, 2022·1 cites·10 claims
- 0277US10478474B2Thymosin alpha 1 for use in treatment of cystic fibrosisSCICLONE PHARMACEUTICALS INT LTD·Filed 2016·Granted Nov 19, 2019·2 cites·10 claims
- 0375US11571465B2Treatment of cancer with alpha thymosin peptide and PD-1 inhibitorsSCICLONE PHARMACEUTICALS INT LTD·Filed 2020·Granted Feb 7, 2023·1 cites·31 claims
- 0462US2021106656A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INT LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCICLONE PHARMACEUTICALS INT LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →